ADVERTORIAL: Answering the question of durability is TAVI’s next challenge
Over the past few years, the indications for transcatheter aortic valve implantation (TAVI) have expanded from inoperable patients to low-risk patients—meaning that TAVI can...
ADVERTORIAl: Edwards PASCAL™ Transcatheter Valve Repair System is associated with a “striking” reduction in...
This content is only for readers outside of the US as it discusses a device that is not FDA approved.
The PASCAL repair system (Edwards...
ADVERTORIAL: Device and procedural innovations have led to improved efficiency with TAVI
Caution: This content is only for readers outside of France and Japan. In the US, ACURATE neo is limited by U.S. law to investigational...
ADVERTORIAL: Edwards PASCAL™ Transcatheter Valve Repair System is innovative
This content is only for readers outside of the US as it discusses a device that is not FDA approved.
On February 12, 2019, Edwards...
ADVERTORIAL: The Edwards Cardioband™ Tricuspid Valve Reconstruction System is associated with considerable improvement in...
This content is only for readers outside of the US as it discusses a device that is not FDA approved.
Until recently, the tricuspid valve...
ADVERTORIAL Early results for HAART 200 and HAART 300 Aortic Annuloplasty Devices are...
The Duke Children’s Pediatric & Congenital Heart Center (Duke University Medical Center, Durham, USA) treats the entire spectrum of patients with complex congenital heart...
ADVERTORIAL: “We are now at a new era of TAVI where we have very...
CAUTION: The ACURATE neo aortic valve system is CE marked. In the USA, it is an investigational device—limited by US law to investigational use...
ADVERTORIAL: Unique design and features of the ACURATE neo (TM) enable safe and efficient...
This content is only for readers outside of the US as it discusses a device that is not FDA approved.
Results from the SAVI-TF Registry1,...
ADVERTORIAL: Rethinking the future of cardiology imaging
This content is only for readers outside of the USA
In an environment with growing demand for specialist cardiology services, it is important that health...
ADVERTORIAL: Edwards’ CardiobandTM Tricuspid Valve Reconstruction System: A new option for under-treated patients
This content is only for readers outside of the US as it discusses a device that is not FDA approved.
The granting of the CE...
ADVERTORIAL: Taking control of LDL-C when statin therapy is not enough
This content is for distribution within the UK only.
This content is for distribution within the UK only.
Currently, statins are the most common lipid-lowering therapy...
Contemporary Issues in Complete Revascularisation
This educational supplement is only for readers in countries outside Europe.
In this educational supplement, sponsored by Boston Scientific, Cardiovascular News explores both complete and...
LAA closure for stroke prophylaxis in atrial fibrillation
This educational supplement is only for readers in countries outside France, Japan and the USA
In this educational supplement, sponsored by Boston Scientific, Cardiovascular News...
Siemens Healthineers’ unique imaging technologies: Smart solutions for challenging patients
In this supplement,* Cardiovascular News reviews how unique imaging technologies provide smart solutions for challenging patients. Contents include:
2 Increase in complex PCI is the “number one” trend in...
Current issues in PCI: The latest data
The first edition of Current issues in PCI, which was published as a supplement alongside the February issue of Cardiovascular News, reported on the...
Current issues in PCI
The Stenting in Complex PCI meeting (2 December 2014, Milan, Italy) reviewed some of the most important issues in percutaneous coronary intervention (PCI) today. This...
DAPT and DES in coronary artery disease: Is it time to revisit the guidelines?
At a roundtable organised by Cardiovascular News, with an unrestricted educational grant from Medtronic, interventional cardiologists Sigmund Silber, Azeem Latib and Alexandre Abizaid discussed...
“Orsiro is a great example of some of the latest developments in DES technology”
Cardiovascular News interviews Francesco Bedogni from Sant’Ambrogio Hospital, Milan, Italy, on the development of drug-eluting stent therapy, crucial factors choosing the right stent for...
